Polymorphism of roxifiban.
Roxifiban was found to exist in two polymorphic forms. The polymorphs were detected by X-ray powder diffraction and solid-state carbon nuclear magnetic resonance. A slight difference between the two polymorphs was also detected by isothermal microcalorimetry. However, no differences were observed by differential scanning calorimetry, infrared, or Raman spectroscopy. Solubility studies as a function of temperature in a discriminating solvent system permitted characterization of the thermodynamics of the polymorphs. The enthalpy of solution at 25 degrees C was 8.1 kcal/mol and 8.9 kcal/mol for Form I and Form II, respectively, and the thermodynamic transition point was 132 degrees C. The data confirm that the polymorphs are enantiotropic. Form II is the thermodynamically stable crystal form over the practical range of drug substance storage and handling and dosage form processing and storage. However, Form I has been kinetically stable after storage for more than 36 months at 25 degrees C/60% relative humidity with no conversion to Form II occurring.
Maurin
Michael B
MB
Pharmacy R&D, DuPont Pharmaceuticals Company, Route 141, Henry Clay Road, Building 400, Wilmington, Delaware 19880-0400, USA. michael.maurin@qspharma.com
Vickery
Rodney D
RD
Rabel
Shelley R
SR
Rowe
Susan M
SM
Everlof
J Gerry
JG
Nemeth
Gregory A
GA
Campbell
G Creston
GC
Foris
C M
CM
D000578:Amidines / Q000032:analysis* / Q000737:chemistry*; D002151:Calorimetry / Q000379:methods; D002626:Chemistry, Pharmaceutical; D007555:Isoxazoles / Q000032:analysis* / Q000737:chemistry*
D000578:Amidines; D007555:Isoxazoles; C118235:roxifiban